Coronavirus immunogenic compositions and uses thereof
US11382968B2 · kind B2 · utility
1Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2021 |
| Grant date | Jul 12, 2022 |
| Priority date | — |
| Expiry date | Jun 9, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided in the present disclosure are immunogenic compounds, pharmaceutical formulations thereof and their use for inducing a protective immune response against 2019 novel coronavirus (SARS-CoV-2) infection and variants in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.